TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pro Health Pharma Sweden AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
21,584
|
19,395 | |
| Financial expenses |
168
|
7 | |
| Earnings before taxes |
662
|
1,128 | |
| EBITDA |
830
|
1,635 | |
| Total assets |
16,412
|
12,702 | |
| Current assets |
13,700
|
11,109 | |
| Current liabilities |
6,311
|
3,111 | |
| Equity capital |
9,899
|
9,389 | |
| - share capital |
100
|
100 | |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
60.3%
|
73.9% | |
| Turnover per employee |
7,195
|
6,465 | |
| Profit as a percentage of turnover |
3.1%
|
5.8% | |
| Return on assets (ROA) |
5.1%
|
8.9% | |
| Current ratio |
217.1%
|
357.1% | |
| Return on equity (ROE) |
6.7%
|
12.0% | |
| Change turnover |
2,189
|
1,520 | |
| Change turnover % |
14%
|
11%
|
9% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.